Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study

Key Points

• This research aims to explore treatment patterns in patients with systemic autoimmune rheumatic disease-associated interstitial lung disease (SARD-ILD) after disease progression.
• Retrospective observational study design
• Analysis of post-progression treatment strategies
• Focus on corticosteroids, DMARDs, and antifibrotics
• High reliance on corticosteroids post-progression
• Limited use of DMARDs and antifibrotics observed
• Indicates a gap in treatment practices versus optimal management guidelines

Abstract